Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Westlake Chemical Shares Decline Following Disappointing Quarterly Results

Andreas Sommer by Andreas Sommer
September 10, 2025
in Analysis, Chemicals, Earnings
0
Westlake Chemical Stock
0
SHARES
170
VIEWS
Share on FacebookShare on Twitter

Westlake Chemical shares experienced downward pressure in recent trading, declining by 1.16 percent to settle at $86.01. This movement extends a broader negative trend for the equity.

Earnings Report Falls Short of Expectations

The company’s August quarterly release significantly impacted investor sentiment with results that missed analyst projections across key metrics:

  • Earnings Per Share: Reported a loss of $0.09, contrasting with the anticipated profit of $0.06
  • Revenue: Totaled $2.95 billion, falling short of the $3 billion forecast
  • Year-Over-Year Sales: Declined by 7.9 percent compared to the same period last year

These weaker-than-expected figures resulted in a net margin of negative 0.57 percent. Market attention is now turning to the upcoming Q3 results, anticipated for release in November.

Mixed Signals from Institutional Investors

Activity among major institutional holders has been varied. Millennium Management LLC aggressively increased its stake by 366.7 percent in the first quarter, building a position exceeding 900,000 shares. Similarly, Vident Advisory LLC grew its investment by a substantial 426.3 percent. Conversely, Jacobs Levy Equity Management Inc. reduced its holdings by 2.9 percent, indicating a more cautious outlook.

Should investors sell immediately? Or is it worth buying Westlake Chemical?

Analyst Sentiment Remains Cautiously Positive

Despite the stock’s recent weakness, the general analyst consensus maintains a guardedly optimistic stance. The average price target currently sits at $92.29, accompanied by a “Moderate Buy” recommendation. This outlook follows some notable adjustments: Truist Financial revised its target down from $117 to $92, though it reaffirmed its “Buy” rating. In a contrasting move, Tudor, Pickering, Holt & Co. upgraded its rating from “Hold” to “Buy” in August.

Dividend Stability and Strategic Growth Initiatives

Amid operational challenges, Westlake Chemical has reaffirmed its commitment to returning capital to shareholders. The company continues its dividend distribution of $0.53 per share, which provides a current yield of approximately 2.4 percent.

In a strategic push for growth, the firm announced the acquisition of the global compounding solutions division of the ACI/Perplastic Group in late August. This purchase is designed to bolster expansion within its Housing & Infrastructure Products segment. Alongside this growth strategy, Westlake is pursuing ambitious environmental targets, including a planned 20 percent reduction in CO2 emissions by 2030.

Ad

Westlake Chemical Stock: Buy or Sell?! New Westlake Chemical Analysis from December 21 delivers the answer:

The latest Westlake Chemical figures speak for themselves: Urgent action needed for Westlake Chemical investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 21.

Westlake Chemical: Buy or sell? Read more here...

Tags: Westlake Chemical
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Viking Therapeutics Stock
Analysis

Analyst Forecasts Near-Triple-Digit Upside for Viking Therapeutics Stock

December 21, 2025
Coeur Mining Stock
Analysis

Coeur Mining’s Meteoric Rise Fueled by Record Gold Prices and Strategic Ambitions

December 21, 2025
Beyond Meat Stock
Analysis

Speculative Surge in Beyond Meat Shares Amid Governance Concerns

December 21, 2025
Next Post
First Watch Restaurant Stock

Major Shareholder Exit Weighs on First Watch Restaurant Stock

Federal Agricultural Mortgage Stock

Leadership Transition at Farmer Mac Amid Market Volatility

Vigil Neuroscience Stock

Vigil Neuroscience Shares Trade in Narrow Range Ahead of Sanofi Acquisition

Recommended

Red Planet Japan Stock

Metaplanet Shares Surge as Bitcoin Strategy Drives Record Forecasts

3 months ago
Alternative Energy Markets and money (1)

Constellation Seeks License Renewal for Clinton Clean Energy Center A Step Towards a Greener Future

2 years ago
Silber Preis Stock

Silver Market Overlooks Looming Supply Crisis

1 month ago
IAC/InterActiveCorp Stock

IAC/InterActiveCorp: A Stock Divided Between Optimism and Operational Reality

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Coinbase Shares Await a Catalyst Amid Crypto Stagnation

UBS Shares Reach Fresh Peak Amid Analyst Praise and Regulatory Relief

QuantumScape Stock Gains Momentum from Dual Catalysts

DeFi Technologies Stock: A Cautious Rebound Amid Legal and Financial Headwinds

Robinhood’s Soaring Stock Faces Scrutiny as Major Holders Cash Out

Ocean Power Gains Analyst Confidence Amid Surging Order Book

Trending

Viking Therapeutics Stock
Analysis

Analyst Forecasts Near-Triple-Digit Upside for Viking Therapeutics Stock

by Robert Sasse
December 21, 2025
0

A prominent analyst at investment bank H.C. Wainwright has reiterated a bullish stance on Viking Therapeutics, setting...

Coeur Mining Stock

Coeur Mining’s Meteoric Rise Fueled by Record Gold Prices and Strategic Ambitions

December 21, 2025
Beyond Meat Stock

Speculative Surge in Beyond Meat Shares Amid Governance Concerns

December 21, 2025
Coinbase Stock

Coinbase Shares Await a Catalyst Amid Crypto Stagnation

December 21, 2025
UBS Stock

UBS Shares Reach Fresh Peak Amid Analyst Praise and Regulatory Relief

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Analyst Forecasts Near-Triple-Digit Upside for Viking Therapeutics Stock
  • Coeur Mining’s Meteoric Rise Fueled by Record Gold Prices and Strategic Ambitions
  • Speculative Surge in Beyond Meat Shares Amid Governance Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com